| 摘要 |
<p>The invention relates to semi-allogenic antigen-presenting cells, in which are introduced proteins and/or peptides, or RNA or DNA or cDNA, coding for said proteins, which are over-expressed in tumour cells, or are derived from autologous tumour cells or various tumour cell lines. The invention relates to methods for generation of semi-allogenic, antigen-presenting cells and use thereof for treatment of tumour diseases.</p> |
